/content/dam/www/people-profile-photos/h/sara-hurvitz/provider-sara-hurvitz-directory-1x.jpg
/content/dam/www/people-profile-photos/h/sara-hurvitz/provider-sara-hurvitz-directory-2x.jpg
Hurvitz
Sara A. Hurvitz, MD, FACP

Sara A. Hurvitz, MD, FACP

Medical Oncology

  • Physician, Fred Hutch
  • Senior Vice President and Director, Clinical Research Division, Fred Hutch
  • Professor, Clinical Research Division, Fred Hutch
  • Smith Family Endowed Chair in Women’s Health, Fred Hutch
  • Affiliate Investigator, Translational Science and Therapeutics Division, Fred Hutch
  • Head and Professor, Division of Hematology and Oncology, University of Washington School of Medicine
Request an Appointment

About

Dr. Sara A. Hurvitz is a board-certified medical oncologist and researcher at Fred Hutch. She specializes in breast cancer and is senior vice president of the Clinical Research Division, leading large-scale clinical research programs while providing patient care.

Background

Dr. Hurvitz is an international expert in breast oncology with extensive experience leading clinical trials across all phases, combining patient care with leadership in clinical and lab-based cancer research.

She is also head of the Division of Hematology and Oncology at the University of Washington Department of Medicine. In her role, she oversees the growth and strategic direction of clinical research programs spanning solid tumors, stem cell transplantation and cell therapy, hematologic cancers and nonmalignant hematology. She works to strengthen the national reputation of Fred Hutch’s solid tumor clinical research program  and oversees the continued growth of clinical research programs in stem cell transplantation and cell therapy, hematologic cancers and nonmalignant hematology.

Dr. Hurvitz has contributed extensively to the growth of clinical research programs since joining the University of California, Los Angeles as a resident in 1999. She is a member of the American College of Physicians, American Society of Hematology, American Society of Clinical Oncology, American Association for Cancer Research and European Society of Medical Oncology.

Area of Clinical Practice
Breast cancer

“Active listening is key. I’m not looking to disrupt any successes. I’m only looking to build on them.”

— Dr. Hurvitz

What is the focus of your work?

My career has focused on the laboratory and clinical evaluation of novel targeted therapeutics for the management of breast cancer. Over almost two decades, I have played a leadership role in the design and implementation of phase I, II, and III national and international breast cancer clinical trials. The results of many of these studies have changed the way we treat breast cancer.

Since transitioning to the Fred Hutch and UW, my goal is to expand the clinical research programs not only for breast cancer but for all of oncology/hematology. To be successful, we will focus on making the process of starting clinical trials more efficient and on expanding the reach of our clinical research into our community sites so that more patients will have access to cutting edge medicines. 

What brought you to Fred Hutch?

I was enticed by the opportunity to learn from and build upon the successes of the legendary hematology and blood and marrow transplant programs and to translate their successes to solid tumor oncology. The prospect of developing programs at a center with such a great foundation, loaded with so much talent, was too good to pass up.

Diseases Treated

Breast Cancer

Research Interests

Preclinical evaluation of novel targeted therapeutics for breast cancer

Development of first-in-human phase I clinical trials of new cancer therapies

Phase II-III clinical trials for breast cancer

Triple negative breast cancer

HER2+ breast cancer

HER2-low breast cancer

Hormone receptor positive breast cancer

Targeted therapies for breast cancer

Languages

English

Education and Experience

Fellowship, Hematology/Oncology, University of California, Los Angeles

Internship and Residency, Internal Medicine, University of California, Los Angeles

MD, University of Southern California

BS (Biology), BA (Psychology), University of California, Irvine

Board Certification

Internal Medicine; Medical Oncology; American Board of Internal Medicine

Clinical Trials

We make promising new treatments available to you through studies called clinical trials led by Fred Hutch physicians and researchers. Many of these trials at Fred Hutch have led to FDA-approved treatments and have improved standards of care globally. Together, you and your physician can decide if a study is right for you.

View Clinical Trials

Publications

Many of our Fred Hutch physicians and researchers conduct ongoing research to improve standards of patient care. Their work is evaluated by others in their field and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this Fred Hutch physician has written.

View Dr. Hurvitz's Publications

Your Care Team

At Fred Hutch, you receive care from a team of providers with extensive experience in your disease. Your team includes physicians, a patient care coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like registered dietitians, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.

Meet Other Providers

Insurance

Fred Hutch accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.

More About Insurance

Stories

All news
Oncology Insights with Dr. Petros Grivas - Episode 14
Oncology Insights with Dr. Petros Grivas - Episode 14 Dr. Sara Hurvitz on clinical trials, multidisciplinary care and leadership in oncology May 20, 2026
SABCS25: What’s new in breast cancer research?
SABCS25: What’s new in breast cancer research? Advances include a new endocrine therapy, the use of ctDNA to predict response and modifying PET/CTs to better track bone metastases December 17, 2025
American Society of Clinical Oncology honors Fred Hutch and UW hematology-oncology fellows
American Society of Clinical Oncology honors Fred Hutch and UW hematology-oncology fellows Five early-career researchers to each receive $50,000 toward innovative cancer research projects June 4, 2025

Contact Information

206.667.5136

206.667.6936